GUARDIGLI, Gabriele
 Distribuzione geografica
Continente #
NA - Nord America 2.803
AS - Asia 1.677
EU - Europa 884
SA - Sud America 351
AF - Africa 41
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.762
Nazione #
US - Stati Uniti d'America 2.726
SG - Singapore 759
CN - Cina 435
BR - Brasile 300
IT - Italia 185
DE - Germania 181
HK - Hong Kong 173
UA - Ucraina 138
VN - Vietnam 111
GB - Regno Unito 98
TR - Turchia 73
FI - Finlandia 53
SE - Svezia 46
RU - Federazione Russa 42
CA - Canada 35
MX - Messico 32
FR - Francia 30
IN - India 27
AR - Argentina 22
ID - Indonesia 21
PL - Polonia 20
ZA - Sudafrica 19
JP - Giappone 18
NL - Olanda 18
BD - Bangladesh 17
ES - Italia 17
LT - Lituania 14
IQ - Iraq 13
CO - Colombia 10
AT - Austria 7
BE - Belgio 7
DK - Danimarca 7
UZ - Uzbekistan 7
MA - Marocco 6
AE - Emirati Arabi Uniti 5
EG - Egitto 5
BO - Bolivia 4
EC - Ecuador 4
IE - Irlanda 4
NZ - Nuova Zelanda 4
VE - Venezuela 4
CH - Svizzera 3
CZ - Repubblica Ceca 3
KE - Kenya 3
PK - Pakistan 3
AL - Albania 2
CL - Cile 2
CR - Costa Rica 2
DZ - Algeria 2
JO - Giordania 2
MY - Malesia 2
PE - Perù 2
PY - Paraguay 2
RO - Romania 2
SV - El Salvador 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CU - Cuba 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
HN - Honduras 1
HU - Ungheria 1
IM - Isola di Man 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
SN - Senegal 1
TG - Togo 1
TL - Timor Orientale 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 5.762
Città #
Singapore 419
Ashburn 361
Woodbridge 210
Santa Clara 183
Chandler 174
Hong Kong 171
Fairfield 167
Jacksonville 150
Beijing 130
Houston 129
Ann Arbor 88
Wilmington 76
Munich 74
Seattle 71
New York 60
Los Angeles 57
Dallas 53
Nanjing 52
Cambridge 46
Princeton 44
Izmir 43
São Paulo 35
Ho Chi Minh City 33
Shanghai 32
Hanoi 30
Boardman 28
Mexico City 26
Milan 26
San Diego 26
Ferrara 24
Bologna 21
London 20
Bremen 19
Denver 19
Warsaw 18
Brooklyn 17
Buffalo 17
Stockholm 17
Tokyo 17
Turku 16
Chicago 15
Atlanta 14
Orem 14
Phoenix 14
Shenyang 14
Hefei 13
Jakarta 13
Falls Church 11
Johannesburg 11
Toronto 11
Montreal 10
Düsseldorf 9
Naples 9
The Dalles 9
Boston 8
Changsha 8
Jiaxing 8
Moscow 8
Nanchang 8
Poplar 8
Rio de Janeiro 8
Tianjin 8
Belo Horizonte 7
Brussels 7
Council Bluffs 7
Dearborn 7
Hebei 7
Helsinki 7
Lauterbourg 7
Rome 7
San Francisco 7
Tashkent 7
Acireale 6
Chennai 6
Da Nang 6
Falkenstein 6
Goiânia 6
Kunming 6
Manchester 6
New Delhi 6
Nuremberg 6
Odense 6
Redwood City 6
Addison 5
Bogotá 5
Erbil 5
Fortaleza 5
Jinan 5
Modena 5
Mumbai 5
Parma 5
San Mateo 5
Ancona 4
Ankara 4
Brasília 4
Cairo 4
Calgary 4
Campina Grande 4
Charlotte 4
Columbus 4
Totale 3.643
Nome #
High-dose BoluS TiRofibAn and Sirolimus eluting STEnt versus abiciximab and bare metal stent in acute MYocardial infarction (STRATEGY) study - Protocol design and demography of the first 100 patients 202
Improved recognition of dysfunctioning myocardial segments by longitudinal strain rate versus velocity in patients with myocardial infarction 172
Reperfusion Damage - A Story of Success, Failure, and Hope 171
Efficacy of angiotensin-converting enzyme inhibitors in secondary prevention 166
Tessuto adiposo epicardico quale nuovo fattore di rischio cardiovascolare 161
Tumor necrosis factor-α receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: The cytokine-activation and long-term prognosis in myocardial infarction (C-ALPHA) study 157
Assessment of left ventricular volume and function by integration of simplified 3D echocardiography, tissue harmonic imaging and automated extraction of endocardial borders 153
EL PENSAMIENTO NARRATIVO PARA CONTRARRESTAR LAS ENFERMEDADES CARDIOVASCULARES. PRIMEROS RESULTADOS DE UN CAMINO DE PREVENCIÓN SECUNDARIA 151
The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty - The ADVANCE trial 150
Bradykinin and coronary artery disease 149
Pathophysiological role of heart rate: from ischaemia to left ventricular dysfunction 144
A modern fairy tale 142
Secondary Prevention of CAD with ACE Inhibitors: A Struggle Between Life and Death of the Endothelium 141
Angiotensin II overproduction: enemy of the vessel wall 140
Electrocardiographic features of 431 consecutive, critically ill COVID-19 patients: An insight into the mechanisms of cardiac involvement 138
Factor XIIIA-V34L and Factor XIIIB-H95R Gene Variants and Survival after Myocardial Infarction. 135
Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial 133
Oltre la dissincronia quali fattori determinano la risposta alla terapia di resincronizzazione cardiaca? 133
Oxidative stress during myocardial ischaemia and heart failure 132
Heart Rate Variability Relates with Competition Performance in Professional Soccer Players 132
The heart rate story 130
CARDIOPROTECTION WITH ACE INHIBITORS: NON-ANGIOTENSIN II-RELATED MECHANISMS 129
CORRENTE IF COME NUOVO TARGET TERAPEUTICO NELL’ANGINA STABILE 125
Tirofiban: A critical reappraisal of the clinical use, recent developments and future perspectives 124
Immune Checkpoint Inhibitors-Associated Myocarditis: Diagnosis, Treatment and Current Status on Rechallenge 121
Interventricular dyssynchrony does not identify CRT responders in patients with heart failure 120
Ferrara VI 117
Screening della fibrillazione atriale nella popolazione generale: esperienza della campagna educazionale sul rischio cardiovascolare della Regione Emilia-Romagna [Screening for atrial fibrillation in the general population: experience from a cardiovascular risk campaign in the Emilia-Romagna Region] 116
Procalcitonin Predicts Bacterial Infection, but Not Long-Term Occurrence of Adverse Events in Patients with Acute Coronary Syndrome 113
In- and out-of-hospital mortality for myocardial infarction during the first wave of the COVID-19 pandemic in Emilia-Romagna, Italy: A population-based observational study 111
Safety and efficacy of new-generation coronary bioresorbable scaffolds 108
Role of duration of post-stress left ventricular dysfunction in the identification of multivassel coronary artery disease: a Tc-99m sestamibi gated-SPECT study 107
FERRARA: CITTÀ DELLA PREVENZIONE 106
Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients. 104
Criteri di appropriatezza nella gestione della terapia ipocolesterolemizzante con alirocumab nel paziente ad alto rischio cardiovascolare. L’opinione di un gruppo multidisciplinare di esperti italiani [Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts] 102
LEFT VENTRICULAR REMODELLING AT THE LIMITS 99
Tirofiban, administered at high dose bolus during coronary angioplasty is highly effective in preventing periprocedural ischemic complications in diabetic patients. Insights into the ADVANCE trial. 97
Ferrara II 92
Three-Dimensional Electro-Anatomical Mapping and Myocardial Work Performance during Spontaneous Rhythm, His Bundle Pacing and Right Ventricular Pacing: The EMPATHY Study 91
Multimodality imaging in acromegalic cardiomiopathy: a case report 85
A COVID-19 specific multiparametric and ECG-based score for the prediction of in-hospital mortality: ELCOVID score 78
ZERO FLUOROSCOPY CARDIAC ABLATION: A NOVEL WORKFLOW FOR ATRIAL FIBRILLATION 78
P299 WATCHMAN DEVICE THROMBOSIS FOLLOWING THE PERCUTANEOUS CLOSURE OF THE LEFT ATRIUM APPENDAGE: A "CUL–DE–SAC" IN THE ANTITHROMBOTIC STRATEGY 75
P1 ATRIAL TACHYCARDIA IN PATIENT WITH TRANSFUSION–DEPENDENT BETA THALASSEMIA AND SEVERE HEMOCHROMATOSIS: A CASE REPORT 70
P422 CARDIOTOXICITY ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITORS: A CLINICAL CASE 67
One-year outcome of elderly patients with endocarditis: a retrospective observational study 66
P18 ATRIAL FIBRILLATION IN BETA–THALASSAEMIA: PHYSIOPATHOLOGY AND CLINICAL MANAGEMENT 63
null 61
The future of cardiovascular prevention: between fiction and reality 60
Tricuspid annular plane systolic excursion to systolic pulmonary artery pressure ratio in Hypertrophic cardiomyopathy 29
Totale 5.846
Categoria #
all - tutte 30.562
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 471
Totale 31.033


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021165 0 0 0 0 0 28 3 38 7 35 39 15
2021/2022361 11 43 24 13 18 18 15 21 14 25 35 124
2022/2023423 40 10 16 44 84 67 20 41 54 6 34 7
2023/2024282 19 37 10 4 13 47 21 23 5 8 14 81
2024/20251.326 23 35 87 71 162 127 44 53 270 126 177 151
2025/20262.043 397 155 276 474 565 176 0 0 0 0 0 0
Totale 5.846